Stockscreener 앱 받기
8.23
4.44%
0.35
시간 외 거래:
7.30
-0.93
-11.30%
Leonabio Inc 주식(LONA)의 최신 뉴스
LONA Q1 2026 Earnings: EPS Surprises Above Estimates Amid Pre-Revenue PhaseGuidance Accuracy Score - newsline.com
LONA Q1 2026 Earnings: Narrowed Loss Exceeds Expectations as Cost Discipline ContinuesEarnings Trend Analysis - newsline.com
LeonaBio (LONA) Holds Steady Near Support as Sector Sentiment WeighsLow Beta Factor - newsline.com
LeonaBio names brelgometon as INN for ALS drug candidate ATH-1105 - Investing.com UK
LeonaBio names brelgometon as INN for ALS drug candidate ATH-1105 By Investing.com - Investing.com South Africa
LeonaBio Presents on ATH-1105 at 5th Annual ALS Drug Development Summit - The Manila Times
LONA Q1 2026 Earnings: Narrower-than-Expected Loss Highlights Progress in Pipeline Despite Market HeadwindsMargin Improvement Report - The Legal Advocate
LeonaBio Inc. (LONA) Q1 2026 Earnings: Surprise EPS Beat Signals Progress Despite Revenue GapEstimate Uncertainty - The Legal Advocate
LeonaBio Gets $20 Price Target Ahead of June Pipeline Test - Bez Kabli
LeonaBio Inc. (LONA) Rises 1.45% as Shares Approach Key Resistance at $10.3Stock News - The Legal Advocate
LONA Initiated Coverage by Piper Sandler -- Rating Set to Overwe - GuruFocus
LeonaBio to Participate in Upcoming Medical and Industry Meetings in June - GlobeNewswire
Piper Sandler initiates LeonaBio stock with overweight rating - Investing.com
Piper Sandler initiates LeonaBio stock with overweight rating By Investing.com - Investing.com Canada
LeonaBio Inc. (LONA) Q1 2026 Earnings: EPS Surprise Provides Bright Spot Amid Revenue Absence and Stock DeclineCash Flow Report - The Legal Advocate
LeonaBio Inc. (LONA) Q1 2026 Earnings: Narrower-Than-Expected Loss Drives Positive Market ReactionOperating Income Trends - The Legal Advocate
LeonaBio Inc. (LONA) Q1 2026 Earnings: Narrower-Than-Expected Loss Buoyed by R&D ProgressEarnings Deceleration Risk - newsline.com
LeonaBio Inc. (LONA) Q1 2026 Earnings: Narrowing Losses Signal Operational DisciplineRetail Earnings Report - Newser
Why Is LeonaBio, Inc. (LONA) Stock Up Today? - Meyka
Why Is LeonaBio, Inc. (LONA) Stock Down Today? - Meyka
ADAR1, Daniel Schneeberger disclose 727,481 shares in LeonaBio (ATHA) - Stock Titan
LeonaBio (ATHA) details 2026 director, auditor and Say-on-Pay votes - Stock Titan
Mizuho Securities Maintains LeonaBio(LONA.US) With Buy Rating, Maintains Target Price $16 - Moomoo
Dividend HistoryLeonaBio, Inc. (LONA) - Zacks Investment Research
LONA: LeonaBio, Inc.Insider Transations - Zacks Investment Research
MSN Money - MSN
LeonaBio (LONA) director receives 56,000 stock options at $9.63 strike - Stock Titan
Director at LeonaBio (LONA) granted 56,000 stock options - Stock Titan
Option grant gives LeonaBio (LONA) director 56,000 shares at $9.63 - Stock Titan
Natalie Holles named LeonaBio (LONA) director in initial Form 3 - Stock Titan
LeonaBio (LONA) director Peter B. Silverman files initial Form 3 - Stock Titan
LeonaBio (LONA) director Callori Fred files baseline Form 3 ownership report - Stock Titan
Perceptive Advisors (ATHA) caps LeonaBio stake at 19.99% and gains board seat - Stock Titan
LeonaBio (NASDAQ: ATHA) widens loss as R&D ramps for lasofoxifene and ALS drug - Stock Titan
LeonaBio (NASDAQ: ATHA) widens Q1 loss while funding late-stage trials - Stock Titan
LeonaBio Reports First Quarter 2026 Financial Results and Provides Business Update - GlobeNewswire
LeonaBio reshapes board with 3 hires as long-serving director exits - Stock Titan
LeonaBio John Fluke Retires, Effective May 4 >LONA - Moomoo
LeonaBio Enhances Board of Directors with Appointments of Fred Callori, J.D., Natalie Holles and Peter B. Silverman, J.D. - Weekly Voice
LeonaBio Enhances Board of Directors with Appointments of - GlobeNewswire
LeonaBio, Inc. (LONA) Stock Forecast 2027, 2031 & 7-Year Price Prediction | Meyka AI - Meyka
How sustainable is LeonaBio (LONA) profit margins? (Selling Pressure) 2026-05-06Hot Market Picks - newser.com
LONA Earnings History & Surprises | EPS & Revenue Results | LEONABIO INC (NASDAQ:LONA) - ChartMill
2.60%
0.94%
자본화:
|
볼륨(24시간):